Control of cellular proliferation by the fibroblast and epidermal growth factors.
Recent studies on the effect of the fibroblast and epidermal growth factors (FGF and EGF, respectively) on the proliferation of ovarian cells and vascular endothelial cells are reviewed. During the ovarian cycle, luteal cells are derived from granulosa cells by a process of cytomorphosis. These two cell types thus allow a study of the changes that occur in growth control when one cell type is converted into another. Also described is the control of vascular endothelial cell proliferation by FGF (but not by EGF). We discuss the effects of FGF and EGF on cells derived from the embryonic ectoderm, mesoderm, and endoderm and examine the hypothesis that cellular specificity for various growth factors is conferred during embryo development. Finally, since antagonists of growth factors are probably as important as the mitogens in the overall control of cell proliferation, we review certain mechanisms and agents through which the mitogenic effect of FGF can be repressed, i.e., cell-cell interaction at confluence, trophic hormones, and a diffusible factor(s) from cartilage.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D002196:Capillaries / Q000166:cytology; D002356:Cartilage / Q000502:physiology; D002450:Cell Communication / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects*; D002478:Cells, Cultured; D004727:Endothelium / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D005260:Female; D005347:Fibroblasts / Q000502:physiology*; D006107:Granulosa Cells / Q000187:drug effects; D006133:Growth Substances / Q000494:pharmacology*; D008184:Luteal Cells / Q000187:drug effects; D008648:Mesoderm / Q000166:cytology; D008934:Mitogens; D010455:Peptides / Q000494:pharmacology*; D011817:Rabbits
D006133:Growth Substances; D008934:Mitogens; D010455:Peptides; D004815:Epidermal Growth Factor; D000324:Adrenocorticotropic Hormone